Skip to content
Lower risk Medical device recall · FDA · Published May 19, 2022

Chromsystems MassCheck Amino Acid Control: Low Glycine Risk

Chromsystems recalls MassCheck Amino Acid, Acylcarnitines Dried Blood Spot Control Level I batch 2821 due to low glycine concentration. Affected units may not provide accurate blood testing results.

🇺🇸 FDA recall #Z-1336-2022Medical deviceChromsystems ›
Take action

Contact the company

Recalling firmChromsystems Instruments & Chemicals GmbHAm Haag 12 · Grafelfing, Germany
✎ GovInfoNow plain-language explainer

What happened, in plain English

Chromsystems is recalling a specific batch of dried blood spot controls because they contain too little glycine. This could lead to inaccurate blood test results if used in medical testing. Read more at govinfonow.com/recall/60689-chromsystems-masscheck-amino-acid-control-low-glycine-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/60689-chromsystems-masscheck-amino-acid-control-low-glycine-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1336-2022

Cite this page

“Chromsystems MassCheck Amino Acid Control: Low Glycine Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/60689-chromsystems-masscheck-amino-acid-control-low-glycine-risk. Based on FDA recall #Z-1336-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1336-2022%22&limit=1).

Why it’s dangerous

The dried blood controls have too low a glycine concentration, which can cause inaccurate blood test results. This means the test might not properly measure amino acids or acylcarnitines in blood samples.

Who’s affected

Users of the MassCheck Amino Acid, Acylc:arnitines Dried Blood Spot Control Level I batch 2821 are affected. Healthcare providers and labs using this product for blood testing may be at risk of inaccurate results.

How to tell if you have this one

Check for the model number 0192 and lot number 2821 on the product label. The product was sold by Chromsystems Instruments & Chemicals GmbH.

  • Brand
    Chromsystems
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US: NY, OH, CT.
Recall numberProduct, codes & lotsQuantity
Z-1336-2022MassCheck Amino Acid, Acylcarnitines Dried Blood Spot Control Level I; Model: 0192; Lot Number: 2821; UDI/DI: 042503175028411330 units
Z-1337-2022MassCheck Amino Acid, Acylcarnitines Dried Blood Spot Control Level II; Model: 0193; Lot Number: 2821; UDI/DI: 042503175028651457 units
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the model number (0192) and lot number (2821) on the product label.

Where it went and when

Where it was distributed

Distributed in 3 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: yesCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “US: NY, OH, CT.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Connecticut, New York, Ohio.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: May 19, 202212. FDA classified it Class II: Jul 6, 202223. Published in FDA’s Enforcement Report: Jul 13, 202234. FDA terminated the recall: May 15, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product dangerous?

No, this is a low-risk issue. The product may not provide accurate blood test results due to low glycine concentration, but it does not pose a direct safety hazard.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1336-2022 (May 19, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1336-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA